Efforts to improve recovery after radical cystectomy (RC) are needed.
To investigate wrist-worn wearable activity trackers in RC participants.
An observational cohort study was conducted within the iROC randomised trial.
Patients undergoing RC at nine cancer centres wore wrist-based trackers for 7 days (d) at intervals before and after surgery.
Step counts were compared with participant and operative features, and recovery outcomes.
Of 308 participants, 284 (92.2%) returned digital activity data at baseline (median 17 d [interquartile range: 8-32] before RC), and postoperatively (5 [5-6] d) and at weeks 5 (43 [38-43] d), 12 (94 [87-106] d), and 26 (192 [181-205] d) after RC. Compliance was affected by the time from surgery and a coronavirus disease 2019 pandemic lockdown (return rates fell to 0-7%, chi-square p < 0.001). Step counts dropped after surgery (mean of 28% of baseline), before recovering at 5 weeks (wk) (71% of baseline) and 12 wk (95% of baseline; all analysis of variance [ANOVA] p < 0.001). Baseline step counts were not associated with postoperative recovery or death. Patients with extended hospital stays had reduced postoperative step counts, with a difference of 2.2 d (95% confidence interval: 0.856-3.482 d) between the lowest third and highest two-third tertiles (linear regression analysis; p < 0.001). Additionally, they spent less time out of the hospital within 90 d of RC (80.3 vs 74.3 d, p = 0.013). Lower step counts at 5, 12, and 26 wk were seen in those seeking medical help and needing readmission (ANOVA p ≤ 0.002).
Baseline step counts were not associated with recovery. Lower postoperative step counts were associated with longer length of stay at the hospital and postdischarge readmissions. Studies are required to determine whether low step counts can identify patients at a risk of developing complications.
Postoperative step counts appear to be a promising tool to identify patients in the community needing medical help or readmission. More work is needed to understand which measures are most useful and how best to collect these.
European urology oncology. 2023 Oct 16 [Epub ahead of print]
Pramit Khetrapal, Parasdeep S Bains, Ibrahim Jubber, Gareth Ambler, Norman R Williams, Chris Brew-Graves, Ashwin Sridhar, Anthony Ta, John D Kelly, James W F Catto, iROC Study Team
Division of Surgery & Interventional Science, University College London, London, UK; Department of Urology, University College London Hospital, London, UK., Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK., Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK; Department of Urology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Department of Statistical Science, University College London, London, UK., Surgical & Interventional Trials Unit (SITU), Division of Surgery & Interventional Science, University College London, London, UK., UCL Centre for Medical Imaging, Division of Medicine, University College London, London, UK., Department of Urology, University College London Hospital, London, UK., Division of Surgery & Interventional Science, University College London, London, UK; Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK; Department of Urology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK. Electronic address: .